Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
Abstract:A B S T R A C T Splanchnic metabolism was studied to quantify changes underlying the fatty liver, hyperlipemia, and hypoglycemia produced by ethanol. Four subjects fasted for 15 h were compared with five subjects fasted for 69 h under basal conditions and during continuous intravenous infusion of sufficient ethanol to give a concentration of 3-5 mM in arterial blood plasma. Splanchnic storage of fatty acids was estimated from the difference between uptake of FFA and secretion of derived products. Basal values … Show more
“…Palmitate comprised an average of 24.2% of the total circulating FFA, a figure that also compares well with reported values (32,34,38). The overall mean palmitate ,umol/kg per min, both values similar to those found in prior investigations (36,37,(39)(40)(41). As noted by others (39,(41)(42)(43)(44), the net inflow transport of fatty acids was directly proportional to the plasma concentration (Fig.…”
A B S T R A C T To determine the plasma epinephrine thresholds for its lipolytic effects, 60-min epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 jg/min were performed in each of four normal young adult men while they also received a simultaneous infusion of [1-13C] 94-101.). Increments in plasma glycerol and free fatty acids and in the inflow and outflow transport of palmitate, however, occurred at lower plasma epinephrine thresholds in the range of 75 to 125 pg/ml. Palmitate clearance was unaffected at any steady-state epinephrine level produced. These data indicate that (a) the lipolytic effects of epinephrine occur at plasma levels approximately threefold basal values and (b) lipolysis is more sensitive than glycogenolysis to increments in plasma epinephrine.
“…Palmitate comprised an average of 24.2% of the total circulating FFA, a figure that also compares well with reported values (32,34,38). The overall mean palmitate ,umol/kg per min, both values similar to those found in prior investigations (36,37,(39)(40)(41). As noted by others (39,(41)(42)(43)(44), the net inflow transport of fatty acids was directly proportional to the plasma concentration (Fig.…”
A B S T R A C T To determine the plasma epinephrine thresholds for its lipolytic effects, 60-min epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 jg/min were performed in each of four normal young adult men while they also received a simultaneous infusion of [1-13C] 94-101.). Increments in plasma glycerol and free fatty acids and in the inflow and outflow transport of palmitate, however, occurred at lower plasma epinephrine thresholds in the range of 75 to 125 pg/ml. Palmitate clearance was unaffected at any steady-state epinephrine level produced. These data indicate that (a) the lipolytic effects of epinephrine occur at plasma levels approximately threefold basal values and (b) lipolysis is more sensitive than glycogenolysis to increments in plasma epinephrine.
“…The shift in the redox state supports a possible mechanism for the inhibition of hepatic gluconeogenesis (HGN) and corroborates the occurrence of alcohol-induced hypoglycemia, especially in malnourished individuals where renal and hepatic glycogen stores are compromised. While not a consistent observation, reports in fasted humans [5][6][7] and fasted rats [8][9][10] have demonstrated a significant decline in blood glucose concentration after a substantial ingestion of ethanol.…”
Section: Consumption On Glucose Homeostasismentioning
Alcohol-induced hypoglycemia has traditionally been attributed to the amount of ethanol consumed rather than any inherent decline in glucose output capacity by the gluconeogenic organs and/or an increase in skeletal muscle glucose uptake. Further, while the potential for sex differences that might impact glucose homeostasis following chronic alcohol consumption has been recognized, direct evidence has been noticeably absent. This paper will provide a brief review of past and present reports of the potential for sex differences in glucose homeostasis following chronic ethanol consumption. This paper will also provide direct evidence from our laboratory demonstrating sex differences from chronic alcohol consumption resulting in a decrement in glucose appearance and more importantly, a specific decline in hepatic gluconeogenic (HGN) capacity in the absence and presence of ethanol. All our studies involved 8 weeks of chronic alcohol consumption in male and female Wistar rats, as well as a 24 to 48 hour fast to deplete hepatic glycogen stores. Under the conditions of chronic alcohol consumption and an acute dose of ethanol, we provide in vivo evidence of an early decline in whole body glucose appearance in females fed an ethanol diet compared to controls.While the decline was also observed in males fed the alcohol diet, it occurred much later compared to ethanol fed females. The site for the decline in whole body glucose production (i.e., either the kidneys or the liver) was beyond the scope of our prior in vivo study. In a follow-up study using the in situ perfused liver preparation, we provide additional evidence for a specific reduction in HGN capacity from lactate in ethanol fed females compared to ethanol fed males in the absence of alcohol in the perfusion medium. Finally, employing the isolated hepatocyte technique, we report decrements in HGN from lactate in ethanol fed females compared to ethanol fed males in the presence of ethanol in the incubation medium.The mechanism for the specific decline in HGN within the liver of ethanol fed females remains to be determined.To the extent that our observations in animals can be extrapolated to humans, we conclude that alcoholic women are more susceptible to ethanol-induced hypoglycemia compared to alcoholic men.
“…This work confirmed that plasma FFA are the predominant source of VLDL-TGFA in postabsorptive humans. By comparing normal with diabetic dogs, 39 normotriglyceridemic subjects with those with primary hypertriglyceridemia 40 and alterations produced by glucose-6-phosphatase deficiency (von Gierke disease) 41 and infusion of ethanol, 42 it became evident that increased secretion of VLDL-triglycerides derived from FFA could account some hypertriglyceridemic states (short-term insulin deficiency, glucose-6-phosphatase deficiency), but not others (long-term insulin deficiency, primary endogenous hypertriglyceridemia). 1 By simultaneously measuring splanchnic fatty oxidation (to CO 2 and ketone bodies), we could estimate splanchnic (presumably hepatic) storage of fatty acids as well.…”
Section: Research At the National Heart Institute (1953 To 1956)mentioning
confidence: 99%
“…45 For example, the reduction in hepatic oxidation of FFA by ethanol in subjects fasted for 3 days led to accumulation of triglycerides in the liver at a rate that could readily account for the rapid development of fatty liver in poorly nourished alcoholics. 42 The status of the liver in glucose-6-phosphatase deficiency indicated a "fed" phenotype (in which oxidation of glycogen replaced that of FFA) with large increases in VLDL-triglyceride production. By contrast, peripheral tissues were confronted with hypoglycemia owing to reduced hepatic glucose production.…”
Section: Research At the National Heart Institute (1953 To 1956)mentioning
Abstract-This memoir provides a history of the triglyceride-rich lipoproteins of blood plasma over the last half-century.As precursors of low-density lipoproteins and in their own right, triglyceride-rich lipoproteins are essential to the formation of atherosclerotic plaques and to consequent ischemic vascular disease. The author recounts research at the National Heart Institute during 1953 to 1956 and continuing thereafter at the University of California San Francisco. Emphasis is placed on key insights arising from investigations of human disease, the interplay of fatty acid and triglyceride-transport involving the liver, small intestine, adipose tissue and muscle, and the role of the liver in the synthesis and catabolism of atherogenic lipoproteins. (Arterioscler Thromb Vasc Biol. 2010;30:9-19.)Key Words: chylomicrons Ⅲ very low-density lipoproteins Ⅲ apolipoproteins Ⅲ lipoprotein receptors Ⅲ atherosclerosis I n 1951, I was one of 8 residents at East Coast medical schools recruited by James Shannon to the National Heart Institute as Clinical Associates to provide care for patients in the Clinical Center of the National Institutes of Health (NIH). At the time, many house officers were being drafted into the U.S. Army for service in Korea. To obviate loss to a "mash" unit, we immediately joined the U.S. Public Health Service. Owing to delays in opening the Clinical Center, I was able to finish my residency at New York Hospital/Cornell Medical Center, arriving in Bethesda in 1953, where by chance I admitted the first inpatient on July 1. In addition to caring for patients our group was expected to engage in research. We were advised to "look around" and select a basic science laboratory to join. During planning for the Clinical Center, Shannon, aware that virtually no NHI scientists were doing "heart" research, asked laboratory heads to suggest appropriate disease-related areas. Christian B. Anfinsen, a protein chemist (and later Nobel laureate for his work on proteinfolding), perused the literature and suggested two topics related to plasma lipids. The first was to investigate the lipemia "clearing factor." At the University of Rochester, Paul Hahn had made a serendipitous observation: in dogs given intravenous heparin, the opalescence of blood plasma occurring postprandially rapidly disappeared. 1 Anfinsen suspected that a protein might be released into the blood by heparin. The second was to investigate the plasma lipoproteins recently described by John Gofman and his students at the University of California Berkeley. They discovered that lipoproteins can be separated from serum by ultracentrifugation and quantified in an analytic ultracentrifuge; and they had reported that a low-density group of these giant macromolecules are risk markers for coronary heart disease. 2 As a result, Anfinsen was asked to organize a new Section in the Laboratory of Metabolism in 1951. Of the 8 who arrived in 1953, Donald Fredrickson, Robert Gordon, and I joined this Section.
Research at the National Heart Institute (1953 to 19...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.